Europe — EMA
Ondansetron Kalceks
Ondondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a 5 mg tablet for oral use. It helps prevent nausea and vomiting associated with chemotherapy, radiation therapy…
Request sourcing
What is Ondansetron?
Ondondansetron, the active ingredient in Ondansetron Kalceks, is a 5-HT3 receptor antagonist presented as a 5 mg tablet for oral use. It helps prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. GNH USA supplies Ondansetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
GNH USA supplies Ondansetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
What is Ondansetron used for?
Ondansetron Kalceks is a selective 5‑HT3 receptor antagonist that works within the vomiting pathway to prevent the onset of nausea and vomiting.
- Chemotherapy‑induced nausea and vomiting: Reduces the frequency and severity of CINV episodes and improves patient comfort. - Post‑operative POST S S S ... .... .... .... .... .... .... .... ... .... ... ... .... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... … … … … … … … … … … … … … … … … … - … .... .... .... .... ... ... ... ... - … … … … … ...
What are the side effects of Ondansetron?
.... ...
Product details
Related products
Ondansetron 2 mg/mL
Ondansetron · 2 mg/mL
Ondansetron 2 mg/mL
Ondansetron · 2 mg/mL
Ondansetron 2 mg/mL
Ondansetron · 2 mg/mL
ONDANSETRON 2 mg/mL
Ondansetron · 2 mg/mL